The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...
Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
TSHA-102 granted Breakthrough Therapy designation by FDAFinalized FDA alignment on REVEAL pivotal trial protocol and SAP, including 6-month ...
Viruses stand as the ocean's most prolific biological entities, vastly surpassing their microbial hosts in number. Long considered merely pathogenic agents, ...
Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...
Can artificial intelligence function as a partner in scientific discovery, capable of generating novel, testable hypotheses ...
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...
Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...
Fungi’s evolutionary roots stretch far deeper than once believed — up to 1.4 billion years ago, long before plants or animals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback